Show simple item record

dc.contributor.authorCohen, Jessica L.
dc.contributor.authorYavuz, Elif Nazmiye
dc.contributor.authorMorris, Alexandra
dc.contributor.authorArkedis, Jean
dc.contributor.authorSabot, Oliver
dc.date.accessioned2013-04-01T19:03:42Z
dc.date.issued2012
dc.identifier.citationCohen, Jessica L, Elif Yavuz, Alexandra Morris, Jean Arkedis, and Oliver Sabot. 2012. Do patients adhere to over-the-counter artemisinin combination therapy for malaria? Evidence from an intervention study in Uganda. Malaria Journal 11:83.en_US
dc.identifier.issn1475-2875en_US
dc.identifier.urihttp://nrs.harvard.edu/urn-3:HUL.InstRepos:10483976
dc.description.abstractBackground: Increasing affordability of artemisinin combination therapy (ACT) in the African retail sector could be critical to expanding access to effective malaria treatment, but must be balanced by efforts to protect the efficacy of these drugs. Previous research estimates ACT adherence rates among public sector patients, but adherence among retail sector purchasers could differ substantially. This study aimed to estimate adherence rates to subsidized, over-the-counter ACT in rural Uganda. Methods: An intervention study was conducted with four licensed drug shops in Eastern Uganda in December 2009. Artemether-lumefantrine (AL) was made available for sale at a 95% subsidy over-the counter. Customers completed a brief survey at the time of purchase and then were randomly assigned to one of three study arms: no follow-up, follow-up after two days or follow-up after three days. Surveyors recorded the number of pills remaining through blister pack observation or through self-report if the pack was unavailable. The purpose of the three-day follow-up arm was to capture non-adherence in the sense of an incomplete treatment course ("under-dosing"). The purpose of the two-day follow-up arm was to capture whether participants completed the full course too soon ("over-dosing"). Results: Of the 106 patients in the two-day follow-up sample, 14 (13.2%) had finished the entire treatment course by the second day. Of the 152 patients in the three-day follow-up sample, 49 (32.2%) were definitely non-adherent, three (2%) were probably non-adherent and 100 (65.8%) were probably adherent. Among the 52 who were non-adherent, 31 (59.6%) had more than a full day of treatment remaining. Conclusions: Overall, adherence to subsidized ACT purchased over-the-counter was found to be moderate. Further, a non-trivial fraction of those who complete treatment are taking the full course too quickly. Strategies to increase adherence in the retail sector are needed in the context of increasing availability and affordability of ACT in this sector.en_US
dc.language.isoen_USen_US
dc.publisherBioMed Centralen_US
dc.relation.isversionofdoi:10.1186/1475-2875-11-83en_US
dc.relation.hasversionhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342228/pdf/en_US
dash.licenseLAA
dc.titleDo patients adhere to over-the-counter artemisinin combination therapy for malaria? Evidence from an intervention study in Ugandaen_US
dc.typeJournal Articleen_US
dc.description.versionVersion of Recorden_US
dc.relation.journalMalaria Journalen_US
dash.depositing.authorCohen, Jessica L.
dc.date.available2013-04-01T19:03:42Z
dc.identifier.doi10.1186/1475-2875-11-83*
dash.contributor.affiliatedYavuz, Elif Nazmiye
dash.contributor.affiliatedCohen, Jessica


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record